Bimatoprost ophthalmic solution 0.01% YSBP

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Bimatoprost ophthalmic solution 0.01% YSBP
Treatment and conditionWhere it standsTrials
Bimatoprost ophthalmic solution 0.01% YSBP for glaucoma, open-anglePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1